JAG2 and neoplasm: In contrast, Jag2 is significantly elevated in metastatic cells compared to those derived from the primary tumors, and in UT-SCC-54C and UT-SCC-74B (metastatic) cells reach ~4-fold and ~6-fold higher expression than their corresponding primary tumor derived counterparts.